75 related articles for article (PubMed ID: 7738670)
1. Potential role of FDG-PET imaging in understanding tumor-host interaction.
Gatenby RA
J Nucl Med; 1995 May; 36(5):893-9. PubMed ID: 7738670
[TBL] [Abstract][Full Text] [Related]
2. Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.
Shulkin BL; Mitchell DS; Ungar DR; Prakash D; Dole MG; Castle VP; Hernandez RJ; Koeppe RA; Hutchinson RJ
Radiology; 1995 Feb; 194(2):495-500. PubMed ID: 7824731
[TBL] [Abstract][Full Text] [Related]
3. FDG-PET evaluation of therapeutic effects on VX2 liver tumor.
Oya N; Nagata Y; Tamaki N; Takagi T; Murata R; Magata Y; Abe M; Konishi J
J Nucl Med; 1996 Feb; 37(2):296-302. PubMed ID: 8667065
[TBL] [Abstract][Full Text] [Related]
4. Fluorodeoxyglucose (FDG) and tumour metabolism.
Van Wyngaarden KE; Pauwels EK
Nucl Med Commun; 1995 Dec; 16(12):987-9. PubMed ID: 8719978
[No Abstract] [Full Text] [Related]
5. Effect of hyperglycemia on in vitro tumor uptake of tritiated FDG, thymidine, L-methionine and L-leucine.
Torizuka T; Clavo AC; Wahl RL
J Nucl Med; 1997 Mar; 38(3):382-6. PubMed ID: 9074524
[TBL] [Abstract][Full Text] [Related]
6. Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET.
Macfarlane DJ; Cotton L; Ackermann RJ; Minn H; Ficaro EP; Shreve PD; Wahl RL
Radiology; 1995 Feb; 194(2):425-9. PubMed ID: 7824722
[TBL] [Abstract][Full Text] [Related]
7. A modeling method to improve quantitation of fluorodeoxyglucose uptake in heterogeneous tumor tissue.
Wu HM; Huang SC; Choi Y; Hoh CK; Hawkins RA
J Nucl Med; 1995 Feb; 36(2):297-306. PubMed ID: 7830134
[TBL] [Abstract][Full Text] [Related]
8. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy].
Mishina M; Senda M; Ohyama M; Ishii K; Kitamura S; Terashi A
Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328
[TBL] [Abstract][Full Text] [Related]
9. Enhanced FDG-PET tumor imaging with correlation-coefficient filtered influx-constant images.
Zasadny KR; Wahl RL
J Nucl Med; 1996 Feb; 37(2):371-4. PubMed ID: 8667078
[TBL] [Abstract][Full Text] [Related]
10. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification?
Hamberg LM; Hunter GJ; Alpert NM; Choi NC; Babich JW; Fischman AJ
J Nucl Med; 1994 Aug; 35(8):1308-12. PubMed ID: 8046485
[TBL] [Abstract][Full Text] [Related]
11. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.
Schmidt K; Lucignani G; Moresco RM; Rizzo G; Gilardi MC; Messa C; Colombo F; Fazio F; Sokoloff L
J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447
[TBL] [Abstract][Full Text] [Related]
12. Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate.
Kuwabara H; Gjedde A
J Nucl Med; 1991 Apr; 32(4):692-8. PubMed ID: 2013809
[TBL] [Abstract][Full Text] [Related]
13. PET cancer evaluations with FDG.
Hawkins RA; Hoh C; Dahlbom M; Choi Y; Glaspy J; Tse N; Slamon D; Chen B; Messa C; Maddahi J
J Nucl Med; 1991 Aug; 32(8):1555-8. PubMed ID: 1869978
[No Abstract] [Full Text] [Related]
14. Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies.
Blacklock JB; Oldfield EH; Di Chiro G; Tran D; Theodore W; Wright DC; Larson SM
J Neurosurg; 1987 Jul; 67(1):71-5. PubMed ID: 3496428
[TBL] [Abstract][Full Text] [Related]
15. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.
Ichiya Y; Kuwabara Y; Otsuka M; Tahara T; Yoshikai T; Fukumura T; Jingu K; Masuda K
J Nucl Med; 1991 Sep; 32(9):1655-60. PubMed ID: 1880564
[TBL] [Abstract][Full Text] [Related]
16. Use of positron emission tomography in oncology.
Glaspy JA; Hawkins R; Hoh CK; Phelps ME
Oncology (Williston Park); 1993 Jul; 7(7):41-6, 49-50; discussion 50-2, 55. PubMed ID: 8347460
[TBL] [Abstract][Full Text] [Related]
17. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
Schröter G; Schneider-Eicke J; Schwaiger M
Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413
[TBL] [Abstract][Full Text] [Related]
18. Quantitating tumor glucose metabolism with FDG and PET.
Hawkins RA; Choi Y; Huang SC; Messa C; Hoh CK; Phelps ME
J Nucl Med; 1992 Mar; 33(3):339-44. PubMed ID: 1740699
[No Abstract] [Full Text] [Related]
19. [18F]fluorodeoxyglucose uptake in tumors: kinetic vs. steady-state methods with reference to plasma insulin.
Minn H; Leskinen-Kallio S; Lindholm P; Bergman J; Ruotsalainen U; Teräs M; Haaparanta M
J Comput Assist Tomogr; 1993; 17(1):115-23. PubMed ID: 8419418
[TBL] [Abstract][Full Text] [Related]
20. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia.
Clavo AC; Brown RS; Wahl RL
J Nucl Med; 1995 Sep; 36(9):1625-32. PubMed ID: 7658223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
